Cipla loses bid to cut short Novo Nordisk’s weight loss drug patent

Intellectual Property 2024-12-13 11:11 pm By Sam Matthews | Melbourne

Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.